Literature DB >> 3919109

Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans.

G F Murphy, Y Merot, A K Tong, B Smith, M C Mihm.   

Abstract

We have observed marked depletion of epidermal dendritic cells, defined by monoclonal antibodies directed against HLA-DR (Ia-like) and T6 antigens, after allogeneic bone marrow transplantation. To more precisely characterize this observation, we examined a total of 39 sequential biopsies from 15 patients both before and after allogeneic bone marrow transplantation. Profound depletion of HLA-DR and T6-positive epidermal dendritic cells was observed early after transplantation (1-4 weeks), followed by gradual and variable repopulation. Transmission electron microscopy confirmed absence of dendritic cells in selected biopsies. Depletion of dendritic cells did not appear to be related to development of clinical or histologic evidence of graft-versus-host disease, suggesting that depletion may relate to pretransplant conditioning regimens. The rate of return of these cells, however, may be influenced by the presence or persistence of clinical disease. Repopulation of epidermal dendritic cells after initial depletion in bone marrow transplantation represents a human model relevant to studies concerned with the origin and kinetics of Langerhans cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919109     DOI: 10.1111/1523-1747.ep12265149

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

Review 1.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

2.  Diminished regulatory T cells in cutaneous lesions of thymoma-associated multi-organ autoimmunity: a newly described paraneoplastic autoimmune disorder with fatal clinical course.

Authors:  T Hanafusa; H Azukizawa; S Kitaba; H Murota; N Umegaki; M Terao; S Sano; T Nakagiri; M Okumura; I Katayama
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

3.  Association of basal-lamina defects with epidermal and dermal T6-positive cells: evidence of Langerhans-cell migration.

Authors:  G F Murphy; E Fonferko; T Flotte; A K Bhan
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohistochemical study.

Authors:  M Drijkoningen; C De Wolf-Peeters; G Tricot; H Degreef; V Desmet
Journal:  Blut       Date:  1988-02

Review 5.  Cutaneous graft versus host disease.

Authors:  J I Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-15

6.  Langerhans' cells are depleted in chronic graft versus host disease.

Authors:  S Aractingi; E Gluckman; M C Dauge-Geffroy; C Le Goué; A Flahaut; L Dubertret; E Carosella
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

7.  Antigen processing: cultured lymph-borne dendritic cells can process and present native protein antigens.

Authors:  L M Liu; G G MacPherson
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

8.  Endothelial-cell injury in cutaneous acute graft-versus-host disease.

Authors:  J S Dumler; W E Beschorner; E R Farmer; K A Di Gennaro; R Saral; G W Santos
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

9.  Phenotypic transformation of macrophages to Langerhans cells in the skin.

Authors:  G F Murphy; D Messadi; E Fonferko; W W Hancock
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

10.  Stimulation of the recruitment of epidermal Langerhans cells by splenopentin.

Authors:  S Gruner; W Diezel; D Strunk; A Zwirner; N Sönnichsen; G J Anhalt
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.